IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.834
EU - Europa 11.160
AS - Asia 8.573
AF - Africa 180
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 41
SA - Sud America 10
Totale 37.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.564
CN - Cina 6.144
IE - Irlanda 3.610
SE - Svezia 3.246
TR - Turchia 1.415
UA - Ucraina 1.201
FI - Finlandia 1.013
SG - Singapore 764
DE - Germania 746
IT - Italia 642
CA - Canada 262
GB - Regno Unito 222
CI - Costa d'Avorio 171
IN - India 115
BE - Belgio 113
EU - Europa 59
AT - Austria 54
FR - Francia 53
NL - Olanda 53
RO - Romania 45
AU - Australia 39
IR - Iran 37
CZ - Repubblica Ceca 31
HU - Ungheria 24
JP - Giappone 21
RU - Federazione Russa 20
KR - Corea 18
ES - Italia 13
PL - Polonia 12
BG - Bulgaria 11
HK - Hong Kong 11
IL - Israele 9
SK - Slovacchia (Repubblica Slovacca) 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
CH - Svizzera 6
RS - Serbia 6
EG - Egitto 5
ID - Indonesia 5
VN - Vietnam 5
BR - Brasile 4
LU - Lussemburgo 4
CL - Cile 3
EE - Estonia 3
GR - Grecia 3
MD - Moldavia 3
PA - Panama 3
PT - Portogallo 3
TW - Taiwan 3
BH - Bahrain 2
EC - Ecuador 2
LK - Sri Lanka 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CR - Costa Rica 1
DK - Danimarca 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
SM - San Marino 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 37.857
Salva come PNG Salva come JPEG
Città #
Chandler 4.808
Dublin 3.602
Dearborn 1.619
Nanjing 1.309
Ashburn 1.297
Izmir 1.234
Jacksonville 1.222
Beijing 1.219
Princeton 831
Shanghai 467
Wilmington 464
San Mateo 446
New York 426
Singapore 411
Ann Arbor 399
Shenyang 372
Nanchang 353
Helsinki 341
Hebei 297
Kunming 239
Toronto 227
Jinan 216
Changsha 203
Jiaxing 198
Tianjin 198
Hefei 182
Kocaeli 174
Boardman 169
Abidjan 165
Parma 147
Norwalk 131
Seattle 108
Hangzhou 105
Brussels 103
Los Angeles 102
Guangzhou 94
Fremont 92
Pune 86
Zhengzhou 79
Des Moines 72
Bremen 70
Chicago 64
Ningbo 64
Vienna 52
Woodbridge 48
Houston 45
Washington 43
Grafing 38
Taizhou 35
Edinburgh 34
Haikou 32
Lanzhou 32
Milan 32
Cambridge 28
Borås 27
Fuzhou 25
Melbourne 25
Shaoxing 25
Chengdu 24
Rockville 24
Taiyuan 24
Wuhan 23
Budapest 22
Leawood 22
Timisoara 20
Xian 20
Bologna 19
Chongqing 19
Redmond 17
Andover 15
Changchun 15
Augusta 14
Rio Saliceto 13
Stockholm 13
Brno 12
Redwood City 11
Sofia 11
Wenzhou 11
Baotou 10
Frankfurt am Main 10
Munich 10
Padova 10
Phoenix 10
Rome 10
Sydney 10
Zanjan 10
Auburn Hills 9
Bucharest 9
Focsani 9
Tokyo 9
Bratislava 8
Dronten 8
Florence 8
London 8
Moscow 8
Quzhou 8
Tappahannock 8
Warsaw 8
Chieti 7
Dubai 7
Totale 25.469
Salva come PNG Salva come JPEG
Nome #
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 119
Approach to gastroenterological diseases in primary care 98
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 84
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 84
Thyroid and celiac disease in pediatric age: a literature review 84
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 84
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 82
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 81
How and when investigating and treating Helicobacter pylori infection in children 81
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 80
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 80
Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H pylori infection? 79
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 78
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 77
Conservative treatment of acute appendicitis 77
Association of keratin 8 gene mutation with chronic pancreatitis 75
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 75
Autoimmune diseases in autoimmune atrophic gastritis 74
Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study 73
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 73
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 73
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 73
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 73
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 72
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 72
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 71
Efficacy of one-week triple therapies with low-dose rabeprazole and clarithromycin plus standard-dose amoxicillin or tinidazole for the cure of H pylori infection in elderly patients 70
Epidemiology and risk factors of pancreatic cancer 70
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 70
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 70
Burning Mouth Syndrome Etiology: A Narrative Review 70
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 69
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 68
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 68
Does chronic hypercalcemia influence serum pepsinogens levels? 68
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 68
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 67
La Biopsie biochimica gastrica 67
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 67
Efficacy of a therapeutic strategy for eradication ofHelicobacter pyloriinfection 67
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 67
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 67
Effects of gastroesophageal reflux disease in laryngeal carcinoma 66
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 66
Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring helicobacter pylori infection: A randomized controlled trial 66
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 66
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 66
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 66
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 66
Advanced gastric cancer: the value of surgery 66
Low-doses versus standard-doses of clarithromicin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 65
Treatment of Helicobacter pylori infection. 65
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 65
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 65
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 65
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 65
Efficacy of 5-ASA in the treatment of colonic diverticular disease 65
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 64
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 64
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia 64
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY 64
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 64
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 64
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 64
Pantoprazole in eradication of peptic ulcer H pylori (Hp) positive patients: a multicentre randomized prospective study by gisu (interdisciplinary ulcer study group) 63
COX1 plus PPI or COX2 in acute osteoarthritis for prevention of gastroduodenal damage ? A prospective four weeks study 63
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 63
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 63
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 63
OC.18.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM ADMINISTRATION: A 6 MONTHS STUDY IN ATROPHIC GASTRITIS SUBJECTS 63
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 63
A new marker for monitoring alcohol abuse? A pilot study on heavy drinkers 63
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 63
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 63
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 62
Prevalence of gastrointestinal diseases in elderly population: epidemiological survey in north-east of Italy 62
Keratin 8 mutations in patients with chronic pancreatitis 62
Are there useful biomarkers for gastric cancer? 62
Acid-related disorders in the elderly 62
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 62
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 62
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 62
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 62
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 62
Emorragia gastrointestinale 62
Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas 62
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 62
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 62
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 62
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 62
Lactoferrin: mechanism of action, clinical significance and therapeutic 61
Gastropanel as screening of gastric atrophy in primary care 61
Prevalence of colorectalcarcinoma in a high risk area of north Italy 61
PANCREATIC PSEUDOCYSTS FOLLOWING ACUTE PANCREATITIS: RISK FACTORS INFLUENCING THERAPEUTIC OUTCOMES 61
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 61
UTILITY OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROPHIC GASTRITIS 61
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon 61
Milk consumption and duodenal ulcer outcome: A short- and long-term study 61
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 61
The Sleeping Remnant. Effect of Roux-En-Y Gastric Bypass on Plasma Levels of Gastric Biomarkers in Morbidly Obese Women: A Prospective Longitudinal Study 61
Totale 6.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.024 2.144 1.042 277 145 562 1.193 817 184 411 789 173 287
2020/20212.322 47 278 272 18 295 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/2025322 322 0 0 0 0 0 0 0 0 0 0 0
Totale 38.573